Sponsor or institution

Clinical trials and research at InnoCare Pharma Inc.

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Comparing Orelabrutinib with standard treatment for mantle cell lymphoma

  This study is testing if adding a new drug called Orelabrutinib to the standard treatment can help older patients with untreated mantle cell lymphoma feel better and improve their outcomes.

  Recruiting at 19 sites Phase 3 InnoCare Pharma Inc. · Beijing and 38 other locations · NCT06363994

• ICP-248 alone or with anti‑CD20 antibodies for relapsed or refractory mature B‑cell malignancies

  This trial tests whether ICP-248 by itself or combined with an anti‑CD20 antibody is safe, tolerable, and shows signs of benefit for adults with relapsed or refractory mature B‑cell malignancies who have had prior therapies including a BTK inhibitor.

  Recruiting at 8 sites Phase 1 InnoCare Pharma Inc. · Plantation, Florida and 7 other locations · NCT06351527

Quick answers

How many clinical trials run by InnoCare Pharma Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (1 trial), Puerto Rico (1 trial), Ukraine (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →